Journey Medical Corp Earnings

The next earnings date for Journey Medical Corp is November 11, 2026.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Journey Medical Corp Earnings

11/11/2026$0.01

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Journey Medical Corp Earnings: Historical

08/12/2026After Market$-0.010.00%
05/13/2026After Market$-0.0811.11%
03/19/2026---$-0.040.00%
11/12/2025After Market$-0.09-125.00%
08/12/2025After Market$-0.16-60.00%
05/14/2025After Market$-0.1825.00%
03/26/2025---$0.10157.97%
11/12/2024After Market$-0.1220.00%
08/12/2024After Market$-0.17-21.43%
05/13/2024After Market$-0.53-130.43%

More About Journey Medical Corp

Country
USA
Full Time Employees
58

Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also provides Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Emrosi for the treatment of inflammatory lesions of rosacea; Exelderm cream and solution for the treatment of fungal skin infections; and Targadox, an oral doxycycline drug for adjunctive therapy for severe acne, as well as Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. The company was formerly known as Coronado Dermatology, Inc. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.

“Journey Medical Corp Earnings” Can Refer to the Journey Medical Corp Earnings Date

Some people say “Journey Medical Corp earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Journey Medical Corp position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Journey Medical Corp Stock on the Earnings Date

If you own Journey Medical Corp stock (DERM) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Journey Medical Corp might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Journey Medical Corp shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Journey Medical Corp Earnings

You can contact us any time if you would like to ask questions about Journey Medical Corp earnings or anything else related to the stock market.